Streetbeat News

Regulatory

EWA

Australia's central bank has decided to keep the interest rate unchanged at 4.35% for March.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 4:46 am

BTCUSD

DOGEUSD

ETHUSD

FTMUSD

Major cryptocurrencies showed mixed performance with Bitcoin and Ethereum experiencing declines, while Dogecoin and others like Fantom saw gains. The decrease in Bitcoin's price is attributed to concerns over an overheated market following spot ETF approvals and a pre-halving drawdown. Spot Bitcoin ETFs saw record inflows, but a subsequent decrease in demand may lead to further price downturns. The stock market rose in anticipation of new Federal Reserve monetary policy guidance. Analysts caution against buying altcoins during rallies, suggesting purchases when they are significantly down.

Portfolio Pulse from Mehab Qureshi

March 19, 2024 | 3:52 am

GOOG

GOOGL

Elon Musk criticized Alphabet Inc. (GOOG, GOOGL) for alleged bias in Google's email filtering and news curation, suggesting it disproportionately affects Republican fundraising and election outcomes. Citing studies and reports, Musk highlighted Google's spam filtering of GOP emails and its news curation favoring left-leaning sources. Musk's comments amplify concerns about Google's political bias and its potential impact on elections.

Portfolio Pulse from Ananya Gairola

March 19, 2024 | 3:31 am

VRNOF

Several cannabis companies, led by Verano Holdings (OTC:VRNOF), are challenging the federal ban on marijuana, arguing that the landscape has changed significantly since many states have legalized marijuana. The lawsuit aims to counter the government's attempt to dismiss the case, citing the reduction in illicit interstate commerce due to state-regulated access. Verano Holdings is highlighted for its standout performance in the cannabis sector, with notable growth in states like Florida, despite challenges in others like Illinois and New Jersey. The company's valuation stands at $2.1 billion, with a 16% stock increase over the last 90 days.

Portfolio Pulse from Nicolás Jose Rodriguez

March 19, 2024 | 1:47 am

USO

Oil prices reached a four-month high, surpassing $82 per barrel, influenced by the U.S. planning to replenish its Strategic Petroleum Reserve, Ukrainian drone strikes on Russian refineries, and a bullish technical outlook as indicated by the United States Oil ETF (USO) exceeding its 200-day moving average. Factors such as China's economic recovery and OPEC+ production cuts also contribute to the tight oil market and positive demand outlook.

Portfolio Pulse from Piero Cingari

March 18, 2024 | 9:34 pm

CC

Chemours received a notice from the NYSE about a delay in filing its Form 10-K. The company has until September 15, 2024, to file the report and regain compliance with NYSE listing standards.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 9:17 pm

WIMI

Wimi Hologram Cloud Inc. has regained compliance with Nasdaq's listing requirements, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:49 pm

TEL

TE Connectivity's Board of Directors has approved the re-incorporation of the company from Switzerland to Ireland. This was formalized through a merger agreement with its subsidiary, TE Connectivity Plc (Ireland), on March 18, 2024. Post-merger, TE Connectivity Ireland will become the public parent company, officially changing TE's jurisdiction of organization to Ireland.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:47 pm

NKLA

Nikola Corporation has announced its ongoing efforts to address a material weakness in its Information Technology General Controls, as well as the successful remediation of a material weakness related to Embedded Derivative Liabilities, as disclosed in its annual Form 10-K report for the year ended December 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:44 pm

QGEN

QIAGEN has partnered with the International Panel Physicians Association (IPPA) to increase awareness and education on tuberculosis (TB) screening, focusing on the Interferon Gamma Release Assay (IGRA) requirements. This collaboration is in response to the CDC's updated TB screening guidelines for U.S. immigrants. QIAGEN's QuantiFERON-TB Plus will play a key role in this initiative, aiming to improve TB detection and support the U.S. strategy to eliminate TB by 2050. The partnership also includes a global event on March 21, 2024, discussing TB infection screening and preventive therapy.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:14 pm